Patricia Eckert, Chief Financial Officer, has been employed with the Company since 2017 and is responsible for corporate finance strategy, global accounting and financial operations, SEC reporting, SOX compliance, and financial planning and analysis. Ms. Eckert previously served as accounting director at Pall Corporation, where she advanced through multiple accounting and finance roles, focusing on accounting operations, finance transformation, and project management. Prior to her tenure at Pall Corporation, Ms. Eckert served as senior accountant at a midsize accounting firm based in New York. She is a CPA, and graduated cum laude with a BBA in accounting and a MBA in finance, both from Hofstra University.

Kara Cannon, Chief Executive Officer, has been employed with the Company since 2011 and is responsible for strategic and tactical marketing, Sales, Manufacturing and general management of the operations . Ms. Cannon previously held executive positions at Pall Corporation, where she focused on commercial operations within the areas of diagnostics, biotechnology and biosciences. She has also held marketing and technical positions at Dynal Biotech (now ThermoFisher Scientific). She has had extensive experience in the marketing and selling of innovative platforms for the diagnostics markets, as well as, the development and execution of strategic plans for the growth and sustainability of diagnostic-related businesses. Ms. Cannon holds a BA from Franklin and Marshall College.